Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (HKG:3378)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
31.98
+2.60 (8.85%)
Apr 17, 2026, 4:08 PM HKT

HKG:3378 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023
Period Ending
Dec '25 Dec '24 Dec '23
Cash & Equivalents
614.4161.21162
Short-Term Investments
-12.6742.36
Trading Asset Securities
37.76--
Cash & Short-Term Investments
652.17173.88204.36
Cash Growth
275.07%-14.92%-
Prepaid Expenses
39.6668.9193.9
Other Current Assets
--0.5
Total Current Assets
691.83242.79298.76
Property, Plant & Equipment
19.9524.1324
Long-Term Investments
222.96233.78262.39
Other Intangible Assets
0.420.450.56
Other Long-Term Assets
0.330.330.53
Total Assets
935.48501.47586.24
Accounts Payable
18.8712.2912.94
Accrued Expenses
-2.82.56
Short-Term Debt
30--
Current Portion of Leases
3.523.173.2
Current Income Taxes Payable
7.027.987.07
Other Current Liabilities
35.71171.237.11
Total Current Liabilities
95.11197.4462.87
Long-Term Debt
17--
Long-Term Leases
5.358.6611.83
Long-Term Deferred Tax Liabilities
70.478.7790.47
Other Long-Term Liabilities
--101.49
Total Liabilities
187.86284.87266.66
Common Stock
13.6211.799.53
Retained Earnings
--72.380.53
Comprehensive Income & Other
684.12226.83258.07
Total Common Equity
697.74166.24268.13
Minority Interest
49.8850.3751.45
Shareholders' Equity
747.62216.6319.58
Total Liabilities & Equity
935.48501.47586.24
Total Debt
55.8611.8315.03
Net Cash (Debt)
596.3162.05189.33
Net Cash Growth
267.98%-14.41%-
Net Cash Per Share
5.0514.8225.95
Filing Date Shares Outstanding
-11.797.3
Total Common Shares Outstanding
-11.797.3
Working Capital
596.7145.35235.89
Book Value Per Share
-14.1036.75
Tangible Book Value
697.32165.79267.57
Tangible Book Value Per Share
-14.0636.68
Machinery
-5.144.1
Construction In Progress
-2.666.41
Leasehold Improvements
-8.2-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.